Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Vermeulin T, Benichou J, Musette P; French study group on autoimmune bullous skin diseases. Joly P, et al. Lancet. 2017 May 20;389(10083):2031-2040. doi: 10.1016/S0140-6736(17)30070-3. Epub 2017 Mar 22. Lancet. 2017. PMID: 28342637 Clinical Trial.
[Cicatricial pemphigoid: treatment with mycophenolate mofetil].
Ingen-Housz-Oro S, Prost-Squarcioni C, Pascal F, Doan S, Brette MD, Bachelez H, Dubertret L. Ingen-Housz-Oro S, et al. Ann Dermatol Venereol. 2005 Jan;132(1):13-6. doi: 10.1016/s0151-9638(05)79188-2. Ann Dermatol Venereol. 2005. PMID: 15746600 Clinical Trial. French.
[Factors associated with delayed diagnosis of bullous pemphigoid].
Ingen-Housz-Oro S, Roujeau JC, Ferranti V, Le Roux-Villet C, Joly P. Ingen-Housz-Oro S, et al. Ann Dermatol Venereol. 2009 Oct;136(10):696-701. doi: 10.1016/j.annder.2009.05.007. Epub 2009 Aug 25. Ann Dermatol Venereol. 2009. PMID: 19801252 French.
Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, Roujeau JC, Bernard P, Guillaume JC, Ingen-Housz-Oro S, Maillard H, Pauwels C, Picard-Dahan C, Dutronc Y, Richard MA; French Study Group for Bullous Diseases. Bastuji-Garin S, et al. J Invest Dermatol. 2011 Mar;131(3):637-43. doi: 10.1038/jid.2010.301. Epub 2010 Oct 14. J Invest Dermatol. 2011. PMID: 20944650 Free article.
[Bullous pemphigoid. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
Bernard P, Bedane C, Prost C, Ingen-Housz-Oro S, Joly P; Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie. Bernard P, et al. Ann Dermatol Venereol. 2011 Mar;138(3):247-51. doi: 10.1016/j.annder.2011.01.009. Ann Dermatol Venereol. 2011. PMID: 21397154 French. No abstract available.
[Pemphigus. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
Joly P, Bernard P, Bedane C, Prost C, Ingen-Housz-Oro S; Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie. Joly P, et al. Ann Dermatol Venereol. 2011 Mar;138(3):252-8. doi: 10.1016/j.annder.2011.01.017. Epub 2011 Feb 22. Ann Dermatol Venereol. 2011. PMID: 21397155 French. No abstract available.
310 results